Patent · US Active

Compounds for treatment of cancer

US9334242B2 · kind B2 · utility

15Cited by
9References
28Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 29, 2010
Grant dateMay 10, 2016
Priority date
Expiry dateJul 2, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.